Ozempic Sales Up 58% As Drugmaker Novo Nordisk Nets Record Profits
Revenue for the Danish company behind the booming GLP-1 injectable drugs is up 29% so far this year.
Revenue for the Danish company behind the booming GLP-1 injectable drugs is up 29% so far this year.